The Psychedelic Report
Opening Doors for Research with Dr. Pam Kryskow and Dr. Zach Walsh
November 20, 2023 · 36 min
Why listen
Researchers behind one of the world's largest microdosing studies share what real-world data actually shows.
0:00––:––
Enjoy the episode?
Subscribe to The Psychedelic Report
Listen & subscribe on
In this episode
- What the Microdose.me study found about everyday microdosing outcomes
- Why real-world studies matter more than controlled trials alone
- Cognitive benefits observed in microdosers over the age of 55
- How this data is shaping the design of future clinical trials
About this episode
Have you ever wondered about the real-world impact of microdosing psychedelics? In this episode, Dr. Dave Rabin interviews Dr. Pamela Kryskow and Dr. Zach Walsh, investigators on the Microdose.me study—one of the world's largest real-world studies on people microdosing psychedelics. Dr. Kryskow and Dr. Walsh discuss their backgrounds and entry into the psychedelic space, emphasizing the importance of observing real-world experiences. The Microdose.me study aims to provide substantial clinical data to support this promising new area of research. Their findings highlight positive outcomes for microdosers, including cognitive benefits for individuals over 55. The researchers stress the challenges of real-world studies, the need for collaboration, and the study's potential to guide future clinical trials.- Web: Microdose.me
- Twitter: https://twitter.com/DrDavidRabin
- Instagram: https://www.instagram.com/drdavidrabin
- Web: https://www.drdave.io/
Learn more about your ad choices. Visit megaphone.fm/adchoices
About The Psychedelic Report
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr.
See all episodes →
